MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14737140.2016.1244008

Медицинская библиотека · Expert review of anticancer therapy · 2016

Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.

Chia Puey Ling, Russell Prudence A, Scott Andrew M, John Thomas

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Malignant mesothelioma (MM) is an aggressive malignancy of the pleura and other serosal membranes originating from mesothelial cells that, despite decades of research, continues to have limited therapeutic options and is associated with a poor prognosis. Areas covered: MMs induce a strong inflammatory response that is also associated with neoangiogenesis and activation of proangiogenic factors. Given this, several anti-angiogenic agents have been trialled in a variety of malignancies including mesothelioma. Herein we summarise the role of angiogenesis in MM and the current available data targeting these pathways. Expert commentary: The addition of bevacizumab to cisplatin/pemetrexed chemotherapy is currently a therapeutic option with a proven 2.7 month overall survival benefit in fit patients less than 75. Other antiangiogenics such as nintedinib show early promise, although the Phase III trial results are eagerly awaited before this therapy enters treatment paradigms. Beyond this, it is likely that combinations of antiangiogenics with immunotherapies will be investigated in future studies.

Для цитирования: Chia Puey Ling, Russell Prudence A, Scott Andrew M, John Thomas. Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.. Expert review of anticancer therapy. 2016. DOI: 10.1080/14737140.2016.1244008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.